IRADIMED CORP - Common Stock, par value $0.0001 per share (IRMD)
CUSIP: 46266A109
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 12,788,649
- Total 13F shares
- 7,049,520
- Share change
- +93,106
- Total reported value
- $421,491,084
- Price per share
- $59.79
- Number of holders
- 160
- Value change
- +$6,336,536
- Number of buys
- 76
- Number of sells
- 71
Quarterly Holders Quick Answers
What is CUSIP 46266A109?
CUSIP 46266A109 identifies IRMD - IRADIMED CORP - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 46266A109:
Top shareholders of IRMD - IRADIMED CORP - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
3.9%
from 13D/G
|
946,300
|
$49,661,823 | — | 31 Mar 2025 | |
| Nine Ten Capital Management LLC |
13F
|
Company |
6.8%
|
872,003
|
$45,763,000 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.3%
|
554,451
|
$29,097,589 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
3.9%
|
501,712
|
$26,329,846 | — | 31 Mar 2025 | |
| Copeland Capital Management, LLC |
13F
|
Company |
3.8%
|
490,544
|
$25,743,797 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
245,390
|
$12,880,071 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.7%
|
220,175
|
$11,554,567 | — | 31 Mar 2025 | |
| Ranger Investment Management, L.P. |
13F
|
Company |
1.6%
|
200,110
|
$10,501,773 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.4%
|
175,682
|
$9,219,791 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.3%
|
169,387
|
$8,889,430 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.2%
|
159,360
|
$8,363,212 | — | 31 Mar 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
1.2%
|
156,319
|
$8,197,000 | — | 31 Mar 2025 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
1.2%
|
153,304
|
$8,045,414 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.79%
|
101,665
|
$5,335,404 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.68%
|
86,869
|
$4,558,937 | — | 31 Mar 2025 | |
| ENVESTNET ASSET MANAGEMENT INC |
13F
|
Company |
0.55%
|
70,473
|
$3,698,439 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.55%
|
70,147
|
$3,681,315 | — | 31 Mar 2025 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.54%
|
69,494
|
$3,647,045 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.51%
|
65,071
|
$3,414,926 | — | 31 Mar 2025 | |
| Bridge City Capital, LLC |
13F
|
Company |
0.48%
|
61,156
|
$3,209,467 | — | 31 Mar 2025 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.47%
|
60,361
|
$3,167,745 | — | 31 Mar 2025 | |
| ISTHMUS PARTNERS, LLC |
13F
|
Company |
0.45%
|
57,800
|
$3,033,344 | — | 31 Mar 2025 | |
| TEACHER RETIREMENT SYSTEM OF TEXAS |
13F
|
Company |
0.4%
|
51,359
|
$2,695,321 | — | 31 Mar 2025 | |
| Uniplan Investment Counsel, Inc. |
13F
|
Company |
0.38%
|
48,727
|
$2,557,285 | — | 31 Mar 2025 | |
| Roubaix Capital, LLC |
13F
|
Company |
0.38%
|
48,126
|
$2,525,652 | — | 31 Mar 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.37%
|
47,573
|
$2,496,631 | — | 31 Mar 2025 | |
| SHAKER INVESTMENTS LLC/OH |
13F
|
Company |
0.34%
|
43,563
|
$2,286,186 | — | 31 Mar 2025 | |
| OAK RIDGE INVESTMENTS LLC |
13F
|
Company |
0.33%
|
41,837
|
$2,195,606 | — | 31 Mar 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.32%
|
41,034
|
$2,153,464 | — | 31 Mar 2025 | |
| Ballast Asset Management, LP |
13F
|
Company |
0.32%
|
40,914
|
$2,147,167 | — | 31 Mar 2025 | |
| Liontrust Investment Partners LLP |
13F
|
Company |
0.32%
|
40,421
|
$2,121,294 | — | 31 Mar 2025 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
0.31%
|
39,074
|
$2,050,000 | — | 31 Mar 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.28%
|
35,900
|
$1,884,032 | — | 31 Mar 2025 | |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.27%
|
34,010
|
$1,784,845 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.26%
|
32,982
|
$1,730,894 | — | 31 Mar 2025 | |
| Aristides Capital LLC |
13F
|
Company |
0.23%
|
29,925
|
$1,570,464 | — | 31 Mar 2025 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.23%
|
29,886
|
$1,568,464 | — | 31 Mar 2025 | |
| Conestoga Capital Advisors, LLC |
13F
|
Company |
0.21%
|
27,455
|
$1,440,838 | — | 31 Mar 2025 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.21%
|
27,067
|
$1,420,000 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.21%
|
27,015
|
$1,417,746 | — | 31 Mar 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.2%
|
25,782
|
$1,354,000 | — | 31 Mar 2025 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.18%
|
23,467
|
$1,231,548 | — | 31 Mar 2025 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.18%
|
23,207
|
$1,217,903 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.18%
|
22,389
|
$1,174,976 | — | 31 Mar 2025 | |
| BANTAMAC CAPITAL, LLC |
13F
|
Company |
0.16%
|
21,076
|
$1,106,068 | — | 31 Mar 2025 | |
| Anthony Vuoto |
3/4/5
|
Director |
—
mixed-class rows
|
20,189
mixed-class rows
|
$1,093,834 | — | 11 Dec 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.16%
|
20,715
|
$1,087,122 | — | 31 Mar 2025 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.16%
|
20,227
|
$1,061,513 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.15%
|
19,301
|
$1,012,916 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.15%
|
19,007
|
$997,487 | — | 31 Mar 2025 |
Institutional Holders of IRADIMED CORP - Common Stock, par value $0.0001 per share (IRMD) as of Q2 2025
As of 30 Jun 2025,
IRADIMED CORP - Common Stock, par value $0.0001 per share (IRMD) was held by
160 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,049,520 shares.
The largest 10 holders included
BlackRock, Inc., Nine Ten Capital Management LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Copeland Capital Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, DIMENSIONAL FUND ADVISORS LP, Ranger Investment Management, L.P., STATE STREET CORP, and ACADIAN ASSET MANAGEMENT LLC.
This page lists
161
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
167
Q2 2025 holders
160
Holder diff
-7
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.